Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia

During the last two decades, epidemiology has undergone a rapid evolution toward collaborative research. The proliferation of multi-institutional, interdisciplinary consortia has acquired particular prominence in cancer research. Herein, we describe the characteristics of a network of 49 established cancer epidemiology consortia (CEC) currently supported by the Epidemiology and Genomics Research Program (EGRP) at the National Cancer Institute (NCI). This collection represents the largest disease-based research network for collaborative cancer research established in population sciences. We describe the funding trends, geographic distribution, and areas of research focus. The CEC have been partially supported by 201 grants and yielded 3,876 publications between 1995 and 2011. We describe this output in terms of interdisciplinary collaboration and translational evolution. We discuss challenges and future opportunities in the establishment and conduct of large-scale team science within the framework of CEC, review future prospects for this approach to large-scale, interdisciplinary cancer research, and describe a model for the evolution of an integrated Network of Cancer Consortia optimally suited to address and support 21st-century epidemiology. Cancer Epidemiol Biomarkers Prev; 22(12); 2148–60. ©2013 AACR.

[1]  M. Pike,et al.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.

[2]  J. Witte,et al.  Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent , 2013, Prostate cancer.

[3]  M. Khoury,et al.  “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Ben Zhang,et al.  Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer , 2012, Nature Genetics.

[5]  Mukesh Verma,et al.  Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[6]  A. Whittemore,et al.  HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) , 2012, Human Genetics.

[7]  J. Potter,et al.  Asia Cohort Consortium: Challenges for Collaborative Research , 2012, Journal of epidemiology.

[8]  Stephanie M Fullerton,et al.  Research guidelines in the era of large-scale collaborations: an analysis of Genome-wide Association Study Consortia. , 2012, American journal of epidemiology.

[9]  Michael J Thun,et al.  Bigger, Better, Sooner–Scaling Up for Success , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Sue Healey,et al.  ENIGMA—Evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes , 2012, Human mutation.

[11]  S. Miller,et al.  Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality , 2012 .

[12]  M. Khoury,et al.  How can we stimulate translational research in cancer genomics beyond bench to bedside? , 2012, Genetics in Medicine.

[13]  D. Noh,et al.  Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. , 2011, Human molecular genetics.

[14]  N. Caporaso,et al.  The Rise of Consortia , 2011 .

[15]  Ákos Végvári,et al.  Biobank resources for future patient care: developments, principles and concepts , 2011, Journal of Clinical Bioinformatics.

[16]  P. Parfrey,et al.  Lynch syndrome: barriers to and facilitators of screening and disease management , 2011, Hereditary cancer in clinical practice.

[17]  Suzanne Chambers,et al.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study , 2011, Nature Genetics.

[18]  John D. Potter,et al.  Coordinating Centers in Cancer Epidemiology Research: the Asia Cohort Consortium Coordinating Center , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[19]  Jane Kaye,et al.  Towards a data sharing Code of Conduct for international genomic research , 2011, Genome Medicine.

[20]  C. Abnet,et al.  Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium , 2011, Gut.

[21]  George A Calin,et al.  Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. , 2011, JAMA.

[22]  Katherine M. Tucker,et al.  Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study , 2011, BJU international.

[23]  Joon-Oh Park,et al.  The Increasing Dominance of Teams in Production of Knowledge , 2011 .

[24]  Ewout W Steyerberg,et al.  The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. , 2011, Gastroenterology.

[25]  R. Malekzadeh,et al.  Cohorts and consortia conference: a summary report (Banff, Canada, June 17–19, 2009) , 2011, Cancer Causes & Control.

[26]  Muin J Khoury,et al.  Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence , 2010, Genetics in Medicine.

[27]  Rosalind Eeles,et al.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. , 2010, JAMA.

[28]  R. Millikan,et al.  MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study , 2010, Cancer Causes & Control.

[29]  T. Sellers,et al.  Fostering Transdisciplinary Science , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[30]  Andrzej Polanski,et al.  Establishment of a Radiogenomics Consortium. , 2010, International journal of radiation oncology, biology, physics.

[31]  John T. Slattery,et al.  The Road We Must Take: Multidisciplinary Team Science , 2010, Science Translational Medicine.

[32]  E. Gillanders,et al.  Translational Research in Cancer Genetics: The Road Less Traveled , 2009, Public Health Genomics.

[33]  D. Winn,et al.  Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium. , 2009, Oral Oncology.

[34]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[35]  A. Onar,et al.  An Operational Perspective of Challenging Statistical Dogma While Establishing a Modern, Secure Distributed Data Management and Imaging Transport System: The Pediatric Brain Tumor Consortium Phase I Experience , 2009, Clinical and translational science.

[36]  S. Gallinger,et al.  Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.

[37]  A. Whittemore,et al.  BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research , 2009, Breast Cancer Research and Treatment.

[38]  Shannon M. Lynch,et al.  Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Causes & Control.

[39]  Kara L Hall,et al.  Moving the science of team science forward: collaboration and creativity. , 2008, American journal of preventive medicine.

[40]  M. C. Leske,et al.  The African-Caribbean Cancer Consortium (AC3) for the study of genetic and viral/environmental cancer risk factors in populations of African descent , 2007 .

[41]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[42]  M. Khoury,et al.  The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? , 2007, Genetics in Medicine.

[43]  M. C. Leske,et al.  African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors , 2007, Infectious Agents and Cancer.

[44]  P. Scheidt,et al.  Cohort profile: the International Childhood Cancer Cohort Consortium (I4C). , 2007, International journal of epidemiology.

[45]  R. Eeles,et al.  A review of targeted screening for prostate cancer: introducing the IMPACT Study , 2007, BJU international.

[46]  Georgia Chenevix-Trench,et al.  An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.

[47]  S. Treves,et al.  The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. , 2007, AJNR. American journal of neuroradiology.

[48]  Paolo Boffetta,et al.  Consortia in Cancer Epidemiology: Lessons from InterLymph , 2007, Cancer Epidemiology Biomarkers & Prevention.

[49]  R. Hoover.  The evolution of epidemiologic research: from cottage industry to "big" science. , 2007, Epidemiology.

[50]  R. Eeles,et al.  AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening. , 2006, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[51]  D. Seminara,et al.  Pancreatic Cancer Genetic Epidemiology Consortium , 2006, Cancer Epidemiology Biomarkers & Prevention.

[52]  D. Schaid,et al.  Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13 , 2005, The Prostate.

[53]  The Polish Breast Cancer Consortium.  A candidate gene approach to searching for low-penetrance breast and prostate cancer genes , 2005 .

[54]  R. Hiatt.  The breast cancer and the environment research centers. , 2005 .

[55]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[56]  Prakash Nadkarni,et al.  The Cancer Genetics Network: Recruitment Results and Pilot Studies , 2003, Public Health Genomics.

[57]  J. Potter,et al.  Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. , 2003, Journal of the National Cancer Institute.

[58]  Ruth Etzioni,et al.  Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer , 2001, Annals of Internal Medicine.

[59]  P. Kantoff,et al.  Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. , 2001, Cancer research.

[60]  M. Tucker,et al.  Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.